Proactiveinvestors Australia Advanced Proteome Therapeutics Corp. https://www.proactiveinvestors.com.au Proactiveinvestors Australia Advanced Proteome Therapeutics Corp. RSS feed en Mon, 21 Sep 2020 18:39:07 +1000 http://blogs.law.harvard.edu/tech/rss Genera CMS action@proactiveinvestors.com (Proactiveinvestors) action@proactiveinvestors.com (Proactiveinvestors) Advanced Proteome Therapeutics to progress two anti-cancer agents to further animal testing after encouraging results https://www.proactiveinvestors.com.au/companies/news/99619/advanced-proteome-therapeutics-to-progress-two-anti-cancer-agents-to-further-animal-testing-after-encouraging-results-51623.html Advanced Proteome Therapeutics (CVE:APC) has discovered that two molecules from the first series of potential anti-cancer agents it is testing have shown "statistically significant retardation" of tumour growth in mice. 

]]>
Wed, 29 Jan 2014 13:38:00 +1100 https://www.proactiveinvestors.com.au/companies/news/99619/advanced-proteome-therapeutics-to-progress-two-anti-cancer-agents-to-further-animal-testing-after-encouraging-results-51623.html
Advanced Proteome Therapeutics signs testing agreement with Stanford University School of Medicine for Foundation Trinity cancer therapy https://www.proactiveinvestors.com.au/companies/news/94896/advanced-proteome-therapeutics-signs-testing-agreement-with-stanford-university-school-of-medicine-for-foundation-trinity-cancer-therapy-43770.html Mon, 13 May 2013 13:39:00 +1000 https://www.proactiveinvestors.com.au/companies/news/94896/advanced-proteome-therapeutics-signs-testing-agreement-with-stanford-university-school-of-medicine-for-foundation-trinity-cancer-therapy-43770.html Advanced Proteome inks first testing agreement with University of Iowa for Foundation Trinity cancer treatment https://www.proactiveinvestors.com.au/companies/news/94585/advanced-proteome-inks-first-testing-agreement-with-university-of-iowa-for-foundation-trinity-cancer-treatment-43225.html Advanced Proteome Therapeutics (APC) (CVE:APC) says it has consummated an agreement with the University of Iowa for Dr. Joel Shilyansky to test the effects of the company's protein conjugates and multimers, as part of the development of APC's Foundation Trinity cancer technology. 

]]>
Mon, 29 Apr 2013 13:23:00 +1000 https://www.proactiveinvestors.com.au/companies/news/94585/advanced-proteome-inks-first-testing-agreement-with-university-of-iowa-for-foundation-trinity-cancer-treatment-43225.html
Advanced Proteome Therapeutics gets notice of issue for new U.S. patent tied to cancer treatment; appoints consultant https://www.proactiveinvestors.com.au/companies/news/94463/advanced-proteome-therapeutics-gets-notice-of-issue-for-new-us-patent-tied-to-cancer-treatment-appoints-consultant-43030.html Tue, 23 Apr 2013 14:14:00 +1000 https://www.proactiveinvestors.com.au/companies/news/94463/advanced-proteome-therapeutics-gets-notice-of-issue-for-new-us-patent-tied-to-cancer-treatment-appoints-consultant-43030.html Advanced Proteome's stock picks up steam, doubles since start of the year https://www.proactiveinvestors.com.au/companies/news/94071/advanced-proteomes-stock-picks-up-steam-doubles-since-start-of-the-year-42349.html Shares of Advanced Proteome Therapeutics (CVE:APC) are up again Thursday, rising more than 29 percent since late February, when the company first announced its business plans for this year, specifically with regards to its potential three-in-one cancer treatment that acts as a targeted, combination and homogeneous therapy - all in a single agent.

]]>
Thu, 04 Apr 2013 18:59:00 +1100 https://www.proactiveinvestors.com.au/companies/news/94071/advanced-proteomes-stock-picks-up-steam-doubles-since-start-of-the-year-42349.html
Advanced Proteome rises as proprietary agents prepared for anti-cancer testing https://www.proactiveinvestors.com.au/companies/news/93636/advanced-proteome-rises-as-proprietary-agents-prepared-for-anti-cancer-testing-41664.html Shares of Advanced Proteome Therapeutics (CVE:APC) moved up Thursday after the company told investors it has prepared its own protein conjugates for testing as part of its potentially groundbreaking anti-cancer therapy. 

]]>
Thu, 14 Mar 2013 17:52:00 +1100 https://www.proactiveinvestors.com.au/companies/news/93636/advanced-proteome-rises-as-proprietary-agents-prepared-for-anti-cancer-testing-41664.html
Advanced Proteome Therapeutics gets “key” patent allowance for Foundation Trinity cancer therapy https://www.proactiveinvestors.com.au/companies/news/93577/advanced-proteome-therapeutics-gets-key-patent-allowance-for-foundation-trinity-cancer-therapy-41564.html Tue, 12 Mar 2013 18:47:00 +1100 https://www.proactiveinvestors.com.au/companies/news/93577/advanced-proteome-therapeutics-gets-key-patent-allowance-for-foundation-trinity-cancer-therapy-41564.html Advanced Proteome Therapeutics hits new 52-week high as plans announced for "multiple warhead" cancer therapy https://www.proactiveinvestors.com.au/companies/news/93316/advanced-proteome-therapeutics-hits-new-52-week-high-as-plans-announced-for-multiple-warhead-cancer-therapy-41080.html Advanced Proteome Therapeutics (CVE:APC) reached a new 52-week high on Wednesday after earlier this week announcing plans for its potentially groundbreaking cancer therapy, with a three-in-one treatment that acts as a targeted, combination and homogeneous therapy - all in a single agent.

]]>
Wed, 27 Feb 2013 17:11:00 +1100 https://www.proactiveinvestors.com.au/companies/news/93316/advanced-proteome-therapeutics-hits-new-52-week-high-as-plans-announced-for-multiple-warhead-cancer-therapy-41080.html
Advanced Proteome Therapeutics embarks on new era of cancer therapy with unique “multiple warhead” platform https://www.proactiveinvestors.com.au/companies/news/93242/advanced-proteome-therapeutics-embarks-on-new-era-of-cancer-therapy-with-unique-multiple-warhead-platform-40943.html Advanced Proteome Therapeutics (CVE:APC) says it has a technology that it likens to a "multiple warhead" in the so-called war on cancer, with a potential three-in-one treatment that acts as a targeted, combination and homogeneous therapy - all in a single agent.

]]>
Mon, 25 Feb 2013 13:13:00 +1100 https://www.proactiveinvestors.com.au/companies/news/93242/advanced-proteome-therapeutics-embarks-on-new-era-of-cancer-therapy-with-unique-multiple-warhead-platform-40943.html
Advanced Proteome to conduct feas study for protein modification technology with large pharma company https://www.proactiveinvestors.com.au/companies/news/74868/advanced-proteome-to-conduct-feas-study-for-protein-modification-technology-with-large-pharma-company-10078.html Mon, 15 Nov 2010 22:46:00 +1100 https://www.proactiveinvestors.com.au/companies/news/74868/advanced-proteome-to-conduct-feas-study-for-protein-modification-technology-with-large-pharma-company-10078.html